When can a company remove factored receivables from its balance sheet?

Factoring receivables means selling them to a third party (a factor) for immediate cash, usually at a discount. The critical accounting question is whether the transaction qualifies as a sale (derecognition) or a secured borrowing.

Sale vs. Secured Borrowing:

When It Qualifies as a Sale (US GAAP — ASC 860):

1. Transferred assets are isolated from the seller (bankruptcy-remote)
2. The buyer can pledge or sell the assets
3. The seller does not maintain effective control

Example: Whitfield Medical has $5 million in receivables. It factors them to Capstone Financial at a 3% discount with no recourse.

True Sale Treatment:

• Remove $5M receivables from balance sheet
• Record $4.85M cash received
• Record $150,000 loss on sale (income statement)

Secured Borrowing Treatment (if recourse exists):

• Keep $5M receivables on balance sheet
• Record $4.85M cash and $4.85M short-term borrowing
• No loss on sale; instead, interest expense over the collection period

Analyst Adjustments for Factoring with Recourse:

If a company uses 'true sale' treatment but has significant recourse, a prudent analyst should:

1. Add receivables back to assets
2. Add an equivalent liability to debt
3. Reclassify the 'loss on sale' as interest expense
4. Reclassify the cash inflow from operating to financing (because it is really a borrowing)

This adjustment is critical because factoring with recourse can make a company's CFO appear artificially high and leverage artificially low.

Red flag for analysts: A company that suddenly increases the volume of factored receivables near quarter-end may be managing its cash flow statement. Look at the footnotes for factoring disclosures and the trend over time.

For more on off-balance-sheet analysis, explore our CFA Level I FRA course materials.